Elsevier

Brain Research

Volume 477, Issues 1–2, 16 January 1989, Pages 166-171
Brain Research

Research report
Glucocorticoid administration increases receptor-mediated and forskolin-stimulated cyclic AMP accumulation in rat brain cerebral cortical slices

https://doi.org/10.1016/0006-8993(89)91404-2Get rights and content

Abstract

Experiments were undertaken to examine the influence of dexamethasone administration on adrenergic receptor-mediated cAMP accumulation in rat brain cerebral cortical slices. While the initial response to continuous treatment with dexamethasone or ACTH was a decrease in the α-adrenergic receptor-mediated augmentation of isoproterenol-stimulated cAMP production, more prolonged administration of these substances also increased β-adrenergic receptor-stimulated cAMP accumulation. Dose-response studies revealed a dose-dependent increase in β-adrenergic receptor-stimulated cAMP production. Prolonged administration of either dexamethasone or ACTH also increased 2-chloradenosine-, vasoactive intestinal peptide (VIP)-, and forskolin-stimulated cAMP production in the brain slice. These results, together with previous findings, suggest that glucocorticoids have at least two effects on the brain neurotransmitter receptor-coupled cAMP generating system which may be important for maintaining homeostasis during times of stress.

References (20)

  • R.S. Duman et al.

    A procedure for measuring α2-adrenergic receptor mediated inhibition of cyclic AMP accumulation in rat brain slices

    Brain Research

    (1986)
  • Y. Salomon et al.

    A highly sensitive adenylate cyclase assay

    Anal. Biochem.

    (1974)
  • M.A. Brostrom et al.

    Adenosine 3′,5′-monophosphate in glial tumor cells treated with glucocorticoids

    Mol. Pharmacol.

    (1974)
  • J.W. Daly et al.

    Fluoronorepinephrine: specific agonists for the activation of alpha and beta adrenergic sensitive cyclic AMP-generating systems in brain slices

    J. Pharmacol. Exp. Ther.

    (1980)
  • R.S. Duman et al.

    Effect of imipramine and adrenocorticotropin administration on the rat brain norepinephrine-coupled cyclic nucleotide system: alterations in alpha and beta adrenergic components

    J. Pharmacol. Exp. Ther.

    (1985)
  • R.S. Duman et al.

    An examination of the involvement of phospholipase A2 and C in the α-adrenergic and γ-aminobutyric acid receptor modulation of cyclic AMP accumulation in rat brain slices

    J. Neurochem.

    (1986)
  • R.S. Duman et al.

    On the relationship between hormones depression and neurotransmitter receptor responses to antidepressants

  • C. Forray et al.

    Glucocorticoids potentiate the prostaglandin E1-mediated cyclic AMP formation by a cultured murine neuroblastoma clone

    J. Neurochem.

    (1985)
  • S.J. Foster et al.

    Glucocorticoids increase the responsiveness of cells in culture to prostaglandin E

  • A. Frazer et al.

    Influence of acute and chronic treatment with desmethylimipramine on catecholamine effects in the rat

    J. Pharmacol. Exp. Ther.

    (1978)
There are more references available in the full text version of this article.

Cited by (39)

  • Chapter 5.1 The intracellular signaling cascade and stress

    2005, Techniques in the Behavioral and Neural Sciences
    Citation Excerpt :

    These studies suggest a bimodal effect of glucocorticoids, in that an initial response to continuous treatment with dexamethasone or ACTH is a decrease in α-adrenergic receptor- stimulated cAMP production but more prolonged administration of these substances also increases β-adrenergic-stimulated cAMP formation. Furthermore, dexamethasone and corticosterone both enhance the sensitivity of the rat brain cAMP-generating system to forskolin (Duman et al., 1989; Czyrak, 1996). Besides the effects of stress or of glucocorticoid administration on cAMP formation, alterations in the expression of adenylyl cyclase have also been reported.

  • Systems mediating acute glucocorticoid effects on memory consolidation and retrieval

    2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry
View all citing articles on Scopus

Present address: Nova Pharmaceutical Corporation, 6200 Freeport Centre, Baltimore, MD 21224, U.S.A.

View full text